The efficacy and safety of pyrotinib in treating HER2-positive metastatic breast cancer patients: a multicenter study
INTRODUCTION: To evaluate the clinical outcomes and safety profile of pyrotinib in HER2-positive metastatic breast cancer (MBC) patients. MATERIAL AND METHODS: This is a multicenter retrospective study. Eligible enrolled HER2-positive MBC patients who received pyrotinib-containing regimens were incl...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Via Medica
2026-07-01
|
| Collection: | Oncology in Clinical Practice |
| Sujets: | |
| Accès en ligne: | https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/105828 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|